Skip to Content

B404 (Meloxicam 7.5 mg)

Pill imprint B404 has been identified as Meloxicam 7.5 mg.

Meloxicam is used in the treatment of osteoarthritis; inflammatory conditions; rheumatoid arthritis; fibromyalgia; juvenile rheumatoid arthritis (and more), and belongs to the drug class nonsteroidal anti-inflammatory agents. Prior to 30 weeks gestation: Risk cannot be ruled out during pregnancy. Starting at 30 weeks gestation: There is positive evidence of human fetal risk during pregnancy. Meloxicam 7.5 mg is not a controlled substance under the Controlled Substance Act (CSA).

Meloxicam
Imprint:
B404
Strength:
7.5 mg
Color:
Yellow
Shape:
Round
Availability:
Prescription only
Drug Class:
Nonsteroidal anti-inflammatory agents
Pregnancy Category:
C - Risk cannot be ruled out - prior to 30 weeks gestation
D - Positive evidence of risk - starting at 30 weeks gestation
CSA Schedule:
Not a controlled drug
Manufacturer:
Breckenridge Pharmaceutical, Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide